No survival benefit from aspirin in COVID-19 patients
The NIHR-supported RECOVERY trial found that the anti-inflammatory drug does not improve survival for hospitalised patients with COVID-19
Read More
Tag: RECOVERY
EMA begins review of Dexamethasone Taw for COVID-19
The medicine is being assessed for treating adults hospitalised with the virus
Read More
Corticosteroids boost survival rates for COVID-19 patients
Four papers have been published reinforcing evidence that steroids can significantly improve the outcomes for those critically ill with the virus
Read More
CMOs urge trusts to continue recruiting for RECOVERY trial
Trusts should aim to recruit at least 60% of eligible COVID-19 patients into trials
Read More
NHS People Plan to address new pandemic challenges
The plan sets out a new a new recruitment, retention and support package
Read More
UK study to research long-term health impact of COVID-19
The PHOSP-COVID study will support the development of new strategies for clinical and rehabilitation care
Read More
Government authorises use of dexamethasone for COVID-19
Doctors can now administer the an anti-inflammatory to all UK hospitalised COVID-19 patients requiring oxygen
Read More
MHRA suspends COVID-19 hydroxychloroquine trials
The move follows data from the RECOVERY trial showing no beneficial effect of the drug in patients hospitalised with COVID-19
Read More
Dexamethasone cut deaths by 35% in ventilated COVID-19 patients
The steroid drug significantly reduced deaths in hospitalised patients with severe respiratory complications
Read More
Researchers look to NHS Digital data in fight against COVID-19
The data is being used by researchers to evaluate the effectiveness of a number of potential treatments
Read More
Psychological therapy recovery rate surpasses 50% for the first time
More than half of patients who finished psychological therapy recovered in 2017-18, marking the first time the recovery rate has passed 50%.
Read More
- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
